Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Marketwired

03:12 EST 22nd January 2018 | BioPortfolio

Here are the most relevant search results for "Marketwired" found in our extensive news archives from over 250 global news sources.

More Information about Marketwired on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Marketwired for you to read. Along with our medical data and news we also list Marketwired Clinical Trials, which are updated daily. BioPortfolio also has a large database of Marketwired Companies for you to search.

Showing News Articles 1–25 of 11,000+ from Marketwired

Saturday 20th January 2018

Avalon GloboCare Corp. CEO David Jin, M.D., Ph.D. to Present and Chair the "China's Impact on The World of Regenerative Medicine" Session at the 13th Annual World Stem Cell Summit

FREEHOLD, NJ--(Marketwired - January 21, 2018) - Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that President and Chief Executive Officer David Jin, M.D., Ph.D. will chair a session entitled, "China's impact on the world of regenerative medicine," and provide a keynote presentation at the 13th Annual World Stem Cell Summit in Miami, F...

Thursday 18th January 2018

Oncolytics Biotech(R) Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patients with Relapsed Metastatic Adenocarcinoma of the Pancreas

CALGARY, AB and SAN DIEGO, CA--(Marketwired - January 19, 2018) - Oncolytics Biotech® Inc. (TSX: ONC) (OTCQX: ONCYF), a biotech company developing REOLYSIN®, also known as pelareorep, an intravenously delivered immuno-oncolytic virus that activates the innate and adaptive immune systems to turn "cold" tumors "hot", today announced that the poster presentation highlighting results from the REO 0...

NanoVibronix CEO Brian Murphy Appears on Varney & Co. on Fox Business; Comments on Role of PainShield in Fighting Opioid Epidemic

ELMSFORD, NY--(Marketwired - January 19, 2018) - NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that Brian Murphy, CEO of NanoVibronix, appeared as a guest on Varney & Co on Fox Business this morning to discuss the benefits of PainShield and its potential role i...

Neptune Announces Research Agreement Aimed at New Medical and Wellness Cannabinoid-based Products

LAVAL, QUEBEC -- (Marketwired) -- 01/19/18 -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (NASDAQ: NEPT)(TSX: NEPT) today announced an exclusive research agreement with the purpose of developing new medical and wellness targeted cannabinoid-based products, such as cannabidiol ("CBD"), combined with krill oil whose combination use would be exclusive to Neptune. ...

Wednesday 17th January 2018

Relevium to Host Webcast to Discuss Previously Announced Blockchain Project

MONTREAL, QUEBEC -- (Marketwired) -- 01/18/18 -- Relevium Technologies Inc. (TSX VENTURE: RLV)(OTC PINK: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce that it will be hosting a webcast in conjunction with Quantomic LLC to discuss Tagspire, the virtual intelligent e-retail platform and artificial intelligence technology stack. Management and the Board of Relevium ha...

Hydropothecary Announces Results of Annual and Special Meeting of Shareholders

GATINEAU, QC--(Marketwired - January 18, 2018) - The Hydropothecary Corporation ("THCX" or the "Company") (TSX VENTURE: THCX) is pleased to announce the results of its annual general and special meeting (the "Meeting") of its shareholders (the "Shareholders") held on January 17, 2018. All items put forth at the Meeting were approved, including the adoption of an advance notice by-law (the "Advance...

Microbix Expands Quality Assessment Product Family

TORONTO, ONTARIO -- (Marketwired) -- 01/18/18 -- Microbix Biosystems Inc. (TSX: MBX) (Microbix®), an innovator of biological products and technologies, announces the expansion of its quality assessment product family, with 48 new products being completed and made available for sale under its PTDx™ and PROCEEDx™ brands. Microbix' quality assessment products are used by clinical laboratories, ...

Tuesday 16th January 2018

Newstrike Announces Shareholder Approval of Plan of Arrangement with CanniMed

TORONTO, ONTARIO -- (Marketwired) -- 01/17/18 -- Newstrike Resources Ltd. (TSX VENTURE: HIP) ("Newstrike" or the "Company") is pleased to announce that at an annual and special meeting of its shareholders held today (the "Meeting"), its shareholders overwhelmingly approved the previously announced proposed plan of arrangement (the "Plan of Arrangement") with CanniMed Therapeutics Inc. ("CanniMed...

Rennova Health's Epic Reference Labs Receives Accreditation From College of American Pathologists

WEST PALM BEACH, FL--(Marketwired - January 17, 2018) - Rennova Health, Inc. (OTCQB: RNVA), (OTCQB: RNVAW) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, that opened its first rural hospital in Oneida, Tenn. in August 2017, announces that its flagship Laboratory, EPIC Reference Labs, Inc. (EP...

Leading Leukemia Experts Join Moleculin's Science Advisory Board

HOUSTON, TX--(Marketwired - January 17, 2018) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The University of Texas System on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced the expansion of its Sc...

Neptune makes its recommendations on Bill 157 special consultations at the National Assembly

LAVAL, QUEBEC -- (Marketwired) -- 01/17/18 -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (NASDAQ: NEPT)(TSX: NEPT) is pleased to announce that it will participate in special consultations on Bill 157, regulating cannabis. Michel Timperio, President of the Cannabis Business division at Neptune, will make a presentation on Wednesday, January 17, 2018, at 2:00 p....

Ceapro to Present at Noble Capital Markets' 14th Annual Investor Conference

EDMONTON, ALBERTA -- (Marketwired) -- 01/17/18 -- Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today that Gilles Gagnon M.Sc., MBA, Ceapro's President and Chief Executive Officer, will present at NobleCon14 - Noble Capital Mar...

NutraFuels, Inc. (NTFU) Year End 2017 Corporate Update

COCONUT CREEK, FL--(Marketwired - January 17, 2018) - NutraFuels Inc. ("NutraFuels" or "NTFU"), (OTC PINK: NTFU), today announced the following corporate update. Increased RevenueAs previously reported NutraFuels achieved record revenue for the 9 months ended September 30th 2017 of $1,030,000.00. Revenue for the quarter ending December 31st 2017 totaled approximately $600,000 ending the fiscal 20...

Trillium Therapeutics Enhances Senior Management Team to Support Further Clinical Development of TTI-621

TORONTO, ONTARIO -- (Marketwired) -- 01/17/18 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced the following key additions to its leadership team: The company also announced that Eric Sievers, MD, has transitioned from Chief Medical Officer to Senior Clinical Advisor. In...

Monday 15th January 2018

Harvest One Announces Filing of Preliminary Short Form Prospectus in Connection with $35 Million Bought Deal Financing and Appointment of Interim COO

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/16/18 -- Filing of Short Form Prospectus Harvest One Cannabis Inc. (TSX VENTURE: HVST) ("Harvest One" or the "Company") is pleased to announce that it has filed a preliminary short form prospectus in each of the provinces of Canada (except Quebec), and obtained a receipt from the British Columbia Securities Commission to qualify the distribution...

Oncolytics Biotech(R) Announces Abstract for Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patients with Relapsed Metastatic Adenocarcinoma of the Pancreas

CALGARY, AB and SAN DIEGO, CA--(Marketwired - January 16, 2018) - Oncolytics Biotech® Inc. (TSX: ONC) (OTCQX: ONCYF), a biotech company developing REOLYSIN®, also known as pelareorep, an intravenously delivered immuno-oncolytic virus that activates the innate and adaptive immune systems to turn "cold" tumors "hot", today announced that the abstract relating to the previously announced poster pre...

Intrinsic4D Announces Shares for Debt Transactions and Convertible Loan Agreement

TORONTO, ONTARIO -- (Marketwired) -- 01/16/18 -- Intrinsic4D Inc. (the "Company") (NEX: IFD.H) announces that it has entered into shares for debt agreements with 65 arm's length creditors, pursuant to which the Company will issue an aggregate of 67,228,184 common shares at a deemed price of $0.05 per share in satisfaction of indebtedness currently owed pursuant to convertible debentures issued b...

Pediapharm Begins Trading on the OTCQB Venture Market

MONTREAL, QUEBEC -- (Marketwired) -- 01/16/18 -- Pediapharm Inc. (the "Company" or "Pediapharm") (TSX VENTURE: PDP) (OTCQB: PDDPF) is pleased to announce that the Company's common shares begin trading today on the OTCQB Venture Market in the United States under the symbol "PDDPF". The Company's common shares will continue to trade under the symbol "PDP" on the TSX Venture Exchange. "Getting lis...

Acasti Pharma Announces Change to Board of Directors

LAVAL, QUEBEC -- (Marketwired) -- 01/16/18 -- Acasti Pharma Inc. (NASDAQ: ACST)(TSX VENTURE: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, today announced that Neptune's representatives, Rick Schottenfeld and Katherine Crewe, have r...

Tetra Bio-Pharma Receives Approval from Health Canada of its Phase 1 Clinical Trial with PPP005 (Cannabis Oil)

OTTAWA, ONTARIO -- (Marketwired) -- 01/16/18 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE: TBP)(OTCQB: TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce that it has received a No Objection Letter (NOL) from the Therapeutic Products Directorate (TPD), Health Canada to evaluate the safety, pharmacokinetics and pharmacodynamics o...

Avalon GloboCare Appoints Dr. Bo Chen as Vice President of Mergers & Acquisitions to Accelerate Growth

FREEHOLD, NJ--(Marketwired - January 16, 2018) - Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that the Company has appointed Dr. Bo Chen as Vice President, Business Development to lead mergers & acquisitions activity. Dr. Chen will focus on executing Avalon's acquisition strategy by helping identify companies with a strategic fit ...

CTD Holdings' European Clinical Trial Adopted by National Institute for Health Research of England

ALACHUA, FL--(Marketwired - January 16, 2018) - CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, announced today that the company's Phase I/II Clinical Trial "A Phase I/II Study to Evaluate the Safety and pK of IV Trappsol® Cyclo™ (HPBCD) in Patients with Niemann-Pick Disease...

Novoheart Files Patent Application on Three-Tier Drug Screening System After Successful Collaboration Contract with Global Pharma Company

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/16/18 -- Novoheart ("Novoheart" or the "Company") (TSX VENTURE: NVH) today announced that it has filed a provisional patent application with the United States Patent and Trademark Office (USPTO) for a three-tiered drug screening system with enhanced capability, sensitivity and accuracy for detecting pharmacological effects on heart contractility ...

BioVie Reviews Key Accomplishments in 2017 and Updates on Phase 2a Clinical Trial Progress

BEVERLY, MA--(Marketwired - January 16, 2018) - BioVie Inc. (OTCQB: BIVI), a clinical-stage company focused on the development and commercialization of innovative drug therapies for liver disease, today reviewed key milestones achieved over the past year and provided a general update on the progress of its mid-stage (Phase 2a) clinical trial of BIV201 in refractory ascites patients. "We made exce...

Sunday 14th January 2018

Imagin Medical Recruits Senior Healthcare Industry CFO

VANCOUVER, BC and BOSTON, MA--(Marketwired - January 15, 2018) - Imagin Medical (CSE: IME) (CSE: IME.CN) (CNSX: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (STUT: DPD2) (the "Company") announced today that it hired John Vacha as the Company's new CFO. Mr. Vacha is a licensed CPA in Massachusetts, holds a MBA and a MS in Accounting from Northeastern University in Boston, Massachusetts, and has 20 yea...


Quick Search
Advertisement

 

News Quicklinks